Orum Therapeutics

News

Ambros' $125m for pain disorder drug, and other financings

Our latest crop of biofinancings has nine-figure rounds for Ambros, Atavistik, Orum, and Addition, with Link Cell and Aeovian also raising new funds.

News

Vertex, Orum partner on safer pre-treatment for gene meds

Vertex Pharma has teamed up with Orum Therapeutics to develop a conditioning regimen, used to prepare patients to receive gene-editing medicines, that it hopes will offer a more tolerable a

News

BMS extends its position in ADCs with $180m Orum deal

Bristol-Myers Squibb has signed another deal to build its capabilities in antibody-drug conjugates for cancer, paying $100 million upfront to take control of an Orum Thera

Ambros' $125m for pain disorder drug, and other financings

Vertex, Orum partner on safer pre-treatment for gene meds

BMS extends its position in ADCs with $180m Orum deal

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Editor's Picks